STOCK TITAN

Harrow Health (HROWL) Free Cash Flow by Year

HROWL NASDAQ

Harrow Health generated $43.0M in free cash flow in fiscal year 2025. The change from the prior fiscal year is not meaningful, because that figure was zero or negative. Over the trailing 12 months, Q2 FY2025 through Q1 FY2026, the same line adds up to $14.3M in free cash flow. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters Harrow Health has filed alongside them.

FY2025 annual
Free Cash Flow $43.0M
YoY n/m
5Y CAGR n/m
10Y CAGR n/m
Source SEC Filings (10-K/10-Q) Latest period Q1 FY2026, ended Mar 31, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

HROWL Free Cash Flow by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricTTMFY2510-KFY2410-KFY2310-KFY22FY21FY20FY19FY18FY17FY16FY15FY14FY13FY12FY11
Free Cash Flow$14.3M$43.0Mn/m-$23.8M-1099.9%$2.4Mn/m-$892K-127.1%$3.3Mn/m-$2.0Mn/m-$518Kn/m-$1.1Mn/m-$9.6Mn/m-$18.1Mn/m-$12.1Mn/m-$7.2Mn/m-$4.5Mn/m-$1.9Mn/m-$291K

TTM is the trailing twelve months, Q2 FY2025 through Q1 FY2026, summed from the four most recent quarterly filings.

HROWL Free Cash Flow by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'24Q4'23Q3'23Q2'23
Free Cash Flow-$9.2M-147.1%$8.1Mn/m$16.4M+597.8%-$969Kn/m$19.5Mn/m-$18.3M-315.6%$2.3Mn/m-$3.1M-171.6%-$4.7Mn/m$8.5Mn/m-$1.7Mn/m$4.3M-6.2%

What free cash flow means

Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper.

More Harrow Health financials

Frequently Asked Questions

Harrow Health generated $43.0M in free cash flow in fiscal year 2025.

Harrow Health (HROWL) reported an outflow of $23.8M in free cash flow in fiscal year 2024 and $43.0M in free cash flow in fiscal year 2025. A growth rate is not meaningful here, because the earlier figure was zero or negative.

Harrow Health (HROWL) reported $14.3M in free cash flow over the trailing 12 months, Q2 FY2025 through Q1 FY2026, summed from the four most recent quarterly filings.

Across the 15 fiscal years this page covers, Harrow Health (HROWL) free cash flow went from -$291K in fiscal year 2011 to $43.0M in fiscal year 2025.

Harrow Health (HROWL) reported -$9.2M in free cash flow in Q1 2026. This represents a decrease of 147.1% from the same quarter a year earlier.

Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper. This page lists what Harrow Health (HROWL) reported on that line in every period on record.